Product Description
Reference Standards &Impurity
AI Product Description
*The following content is generated by AI and is for reference only.
Efinaconazole is a modern, broad-spectrum antifungal agent belonging to the triazole class of medications. Chemically known as 1-[(2S)-2-(4-chlorophenyl)-3-methylbutan-2-yl]-1H-pyrazole-3-carbonitrile, it is specifically formulated for the topical treatment of onychomycosis, commonly referred to as fungal nail infections. The molecular formula of Efinaconazole is C18H19ClN4, and its unique chemical structure allows for high potency against dermatophytes, yeasts, and molds. The compound is identified by the CAS Registry Number 207652-23-3.
Unlike many older systemic antifungals that require oral administration and carry risks of hepatotoxicity, Efinaconazole is designed for external use only. It is typically available as a clear, colorless solution applied directly to the affected toenails and surrounding skin. A key advantage of this formulation is its ability to penetrate the nail plate effectively due to its low surface tension and high solubility in the lipid-rich environment of the nail. This penetration capability ensures that the drug reaches the site of infection deep within the nail bed where fungi reside.
The primary mechanism of action involves the inhibition of the enzyme lanosterol 14α-demethylase, which is encoded by the CYP51 gene. By blocking this enzyme, Efinaconazole prevents the conversion of lanosterol to ergosterol, an essential component of the fungal cell membrane. Without ergosterol, the fungal cell membrane becomes unstable and permeable, leading to cell death and the cessation of fungal growth. Clinical studies have demonstrated high cure rates for mild-to-moderate distal subungual onychomycosis when used consistently over a prolonged period, often requiring daily application for up to 48 weeks.
Due to its favorable safety profile and lack of significant systemic absorption, Efinaconazole is suitable for patients who cannot tolerate oral antifungal therapy or those with underlying liver conditions. It represents a significant advancement in dermatological care, offering a non-invasive, effective solution for restoring healthy nail appearance and function. Its development marks a shift toward targeted, localized therapies that minimize systemic side effects while maximizing therapeutic efficacy against stubborn fungal infections of the nails.